Twist Bioscience (TWST) Restructuring Costs (2019 - 2026)
Twist Bioscience (TWST) posted quarterly Restructuring Costs of $7.2 million for Q1 2026, down 67.98% quarter-over-quarter from $22.5 million in Q4 2019.
Twist Bioscience (TWST) Restructuring Costs (2019 - 2026) Analysis & Trends
Twist Bioscience (TWST) has reported Restructuring Costs for 2 consecutive years, with $7.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Restructuring Costs changed N/A year-over-year to $7.2 million; the TTM figure through Mar 2026 stood at $7.2 million (changed N/A YoY), while the FY2020 annual figure was $22.5 million, changed N/A from the prior year.
- Restructuring Costs slipped to $7.2 million in Q1 2026 per TWST's latest filing, from $22.5 million in the prior quarter.
- Across five years, Restructuring Costs topped out at $7.2 million in Q1 2026 and bottomed at $7.2 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Twist Bioscience | 7.18 Bn | 7.02 Bn | 62.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.21 Mn |
| Dec 31, 2019 | 22.50 Mn |